Patents Assigned to NitroSci Pharamaceuticals, Inc.
  • DAB-4 LINKED NITROXIDE CITRATE, USEFUL AS MRI CONTRAST AGENT
    Publication number: 20180256759
    Abstract: A method of imaging a joint of a subject comprises administering to the subject an amount of a salt of DAB-4 linked nitroxide citrate effective to enhance an MRI image of the joint and taking an MRI image of said joint.
    Type: Application
    Filed: March 9, 2018
    Publication date: September 13, 2018
    Applicant: NitroSci Pharamaceuticals, Inc.
    Inventors: Gerald M. ROSEN, Erika SCHNEIDER